News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Advent To Sell German Pharmaceutical Group VIATRIS To Meda AB For 750 Million Euros


10/19/2005 5:09:07 PM

Viatris has operations through own affiliates in 14 countries with a strong focus on larger European markets. The company's most important therapeutic area is respiratory. It also has a strong position in the therapeutic area of pain/inflammation, which is a core therapeutic area for Meda.

Read at press release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES